Evidence map›Paper›PMID 24732876›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2014

Altered innate immune development in HIV-exposed uninfected infants.

Brian A Reikie, Rozanne C M Adams, Aleksandra Leligdowicz, Kevin Ho, Shalena Naidoo, Candice E Rusk, Corena de Beer, Wolfgang Preiser, Mark F Cotton, David P Speert and 2 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Brian A ReikieDivision of Infectious & Immunological Diseases, and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, V5Z 4H4, Canada.
Rozanne C M AdamsImmunology Unit, Division of Medical Microbiology, Department of Pathology, NHLS and Stellenbosch University, PO 19063, Tygerberg 7505 South Africa.
Aleksandra LeligdowiczDivision of Infectious & Immunological Diseases, and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, V5Z 4H4, Canada.
Kevin HoDivision of Infectious & Immunological Diseases, and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, V5Z 4H4, Canada.
Shalena NaidooImmunology Unit, Division of Medical Microbiology, Department of Pathology, NHLS and Stellenbosch University, PO 19063, Tygerberg 7505 South Africa.
Candice E RuskDivision of Infectious & Immunological Diseases, and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, V5Z 4H4, Canada.
Corena de BeerDivision of Medical Virology, Department of Pathology, NHLS and Stellenbosch University, PO 19063, Tygerberg 7505 South Africa.
Wolfgang PreiserDivision of Medical Virology, Department of Pathology, NHLS and Stellenbosch University, PO 19063, Tygerberg 7505 South Africa.
Mark F CottonDepartment of Paediatrics and Child Health, Tygerberg Children's Hospital and Stellenbosch University, PO 19063, Tygerberg 7505 South Africa.
David P SpeertDivision of Infectious & Immunological Diseases, and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, V5Z 4H4, Canada.
Monika Esser *Immunology Unit, Division of Medical Microbiology, Department of Pathology, NHLS and Stellenbosch University, PO 19063, Tygerberg 7505 South Africa.
Tobias R Kollmann *Division of Infectious & Immunological Diseases, and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, V5Z 4H4, Canada.

Funding

IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050023N01AI050023 · NIAID · UNIVERSITY OF WASHINGTON · PI WILSON, CHRISTOPHER · 2006 to 2006
–
NIAID NIH HHS N01 AI050023
6 · The paper itself

Abstract

backgroundEarly in life, HIV-exposed uninfected (HEU) infants are at an increased risk of morbidity and mortality from infectious disease compared with HIV-unexposed (UE) infants. To improve our understanding of the mechanisms underlying their increased risk, we contrasted innate immune development between HEU and UE infants in a developing world setting, where early life infectious disease risk is exceptionally high.

methodsA prospective longitudinal cohort of HEU and UE newborns was established, and the most detailed characterization to date of HEU infant immune development was performed. Single-cell cytokine production was analyzed by flow cytometry after stimulation of whole blood with pathogen-associated molecular patterns (PAMPs).

resultsMonocyte, classical dendritic cell, and plasmacytoid dendritic cell composition was similar between HEU and UE infants throughout the first year of life. However, HEU mononuclear cells mounted an enhanced pro-inflammatory response to PAMP stimulation, both in quantity of cytokine produced per cell and in proportion of responder cells. Significant differences in cytokine production were detected on the single-cell level in a PAMP-specific pattern, but only at 2 and 6 weeks of age; all differences normalized by 12 months of age.

conclusionsThis time course of innate immune deviation early in life corresponds to the clinical window of vulnerability to infections in HEU infants and may be at least partially responsible for their increased morbidity and mortality from infectious disease.

Indexed as

Infectious Disease Transmission, VerticalCytokinesDendritic CellsFemaleHIV InfectionsHIV SeronegativityHumansImmunity, InnateInfant, NewbornLongitudinal StudiesMaleMonocytesPregnancyPregnancy ComplicationsProspective StudiesSouth AfricaCytokines

Identifiers

PMID24732876
PMCPMC4146715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.